AI blood test could catch lung cancer early in smokers with COPD
NCT ID NCT07552584
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a simple blood test, combined with artificial intelligence (AI), can help find lung cancer early in people with COPD who are current or former smokers. About 1,000 participants will give a blood sample, and those flagged as high-risk by the AI will get a low-dose CT scan. The goal is to see if this approach is practical and safe for use in primary care, potentially catching cancer sooner and reducing unnecessary scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General practices, Vejle area
RECRUITINGVejle, Denmark
-
Lillebaelt Hospital Vejle, University Hospital of Southern Denmark
RECRUITINGVejle, 7100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which lung biopsy method is safer and more accurate?
- Light-Based blood test may spot lung cancer early
- Could a nebulized cocktail make lung scopes less Cough-Inducing?
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
- Can a simple blood test predict leukemia risk after cancer therapy?